XML 60 R42.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Debt and Credit Facilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Debt Disclosure [Abstract] |
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments | A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below:
|  | December 31, 2023 |  | December 31, 2022 |
|  | Fair Value |  | Carrying Value |  | Fair Value |  | Carrying Value |
| 5.750% Senior Notes due 2033 | $ | 758,783 |  |  | $ | 741,124 |  |  | $ | — |  |  | $ | — |  |
| 3.600% Senior Notes due 2029 | 371,276 |  |  | 395,137 |  |  | 362,644 |  |  | 394,221 |  |
| 3.450% Senior Notes due 2027 | 283,350 |  |  | 298,270 |  |  | 280,506 |  |  | 297,775 |  |
| 3.700% Senior Notes due 2025 | 293,154 |  |  | 299,537 |  |  | 290,874 |  |  | 299,168 |  |
| 4.750% Senior Notes due 2025 (DaVinci) (1) | 147,489 |  |  | 149,587 |  |  | 146,625 |  |  | 149,278 |  |
| Total senior notes | 1,854,052 |  |  | 1,883,655 |  |  | 1,080,649 |  |  | 1,140,442 |  |
| Medici Revolving Credit Facility (2) | 75,000 |  |  | 75,000 |  |  | 30,000 |  |  | 30,000 |  |
| Total debt | $ | 1,929,052 |  |  | $ | 1,958,655 |  |  | $ | 1,110,649 |  |  | $ | 1,170,442 |  |
(1) RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions. (2) RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s outstanding issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions. Subsequent to December 31, 2023, Medici repaid in full the aggregate principal amount drawn under the Medici Revolving Credit Facility.
Schedule of Aggregate Amount of Maturities Related to the Company's Debt Obligations | The following table sets forth the scheduled maturity of the Company’s aggregate amount of its debt obligation reflected on its consolidated balance sheet at December 31, 2023:
| 2024 | $ | 75,000 |  |
| 2025 | 450,000 |  |
| 2026 | — |  |
| 2027 | 300,000 |  |
| 2028 | — |  |
| After 2028 | 1,150,000 |  |
| Unamortized fair value adjustments | — |  |
| Unamortized discount and debt issuance expenses | (16,345) |  |
|  | $ | 1,958,655 |  |
Schedule of Credit Facilities | The outstanding amounts issued or drawn under each of the Company’s significant credit facilities is set forth below:
| At December 31, 2023 | Issued or Drawn |
| Revolving Credit Facility (1) | $ | — |  |
| Medici Revolving Credit Facility (2) | 75,000 |  |
| Bilateral Letter of Credit Facilities |  |
| Secured | 571,625 |  |
| Unsecured | 709,740 |  |
| Funds at Lloyd’s Letter of Credit Facility | 225,000 |  |
|  | $ | 1,581,365 |  |
(1)At December 31, 2023, no amounts were issued or drawn under this facility. (2)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s outstanding voting rights, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. The drawn amount of the Medici revolving credit facility is included on the Company’s consolidated balance sheets under debt. Subsequent to December 31, 2023, Medici repaid in full the aggregate principal amount drawn under the Medici Revolving Credit Facility.

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturity and sinking fund requirement for long-term debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1 + Details
Name: | us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration